Detalles de la búsqueda
1.
Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New York.
Catheter Cardiovasc Interv;
101(6): 980-994, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37002950
2.
Sex differences in the treatment and outcomes of patients hospitalized with ST-elevation myocardial infarction.
Catheter Cardiovasc Interv;
95(2): 196-204, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31012227
3.
Assessment of repeat target lesion percutaneous coronary intervention as a quality measure for public reporting and general quality assessment for PCIs.
Catheter Cardiovasc Interv;
96(4): 731-740, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31642597
4.
Impact of Regionalization of ST-Segment-Elevation Myocardial Infarction Care on Treatment Times and Outcomes for Emergency Medical Services-Transported Patients Presenting to Hospitals With Percutaneous Coronary Intervention: Mission: Lifeline Accelerator-2.
Circulation;
137(4): 376-387, 2018 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29138292
5.
Plasma Ceramides.
Arterioscler Thromb Vasc Biol;
38(8): 1933-1939, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29903731
6.
Regional Systems of Care Demonstration Project: American Heart Association Mission: Lifeline STEMI Systems Accelerator.
Circulation;
134(5): 365-74, 2016 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27482000
7.
Incomplete revascularization for percutaneous coronary interventions: Variation among operators, and association with operator and hospital characteristics.
Am Heart J;
186: 118-126, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454825
8.
Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial.
Catheter Cardiovasc Interv;
89(2): 190-198, 2017 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26909669
9.
Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network.
Catheter Cardiovasc Interv;
89(2): 245-251, 2017 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27142567
10.
Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent?
Eur Heart J;
37(16): 1284-95, 2016 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-26712838
11.
Appending Limited Clinical Data to an Administrative Database for Acute Myocardial Infarction Patients: The Impact on the Assessment of Hospital Quality.
Med Care;
54(5): 538-45, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27078825
12.
Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States.
Am Heart J;
170(4): 706-14, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26386794
13.
Assessing hospital performance for acute myocardial infarction: how should emergency department transfers be attributed.
Med Care;
53(3): 245-52, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25675402
14.
Does Preoperative Platelet Function Predict Bleeding in Patients Undergoing Off Pump Coronary Artery Bypass Surgery?
J Interv Cardiol;
28(3): 223-32, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25991082
15.
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.
Lancet;
382(9906): 1714-22, 2013 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24004642
16.
Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.
N Engl J Med;
365(21): 1980-9, 2011 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-22077909
17.
Safety of coronary angiography and percutaneous coronary intervention via the radial versus femoral route in patients on uninterrupted oral anticoagulation with warfarin.
Am Heart J;
168(4): 537-44, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25262264
18.
Finding the Proper Context for the MATRIX Trial.
N Engl J Med;
373(11): 1069-70, 2015 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26324050
19.
Would tirofiban have been shown non-inferior to abciximab had the TENACITY trial not been terminated for financial reasons?
J Interv Cardiol;
26(2): 123-30, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23379785
20.
Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction.
J Interv Cardiol;
26(6): 623-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24118114